Radium-223 systemic alpha-radiotherapy: targeted treatment of castration-resistant prostate cancer with bone metastases

In Russia, approaches to treatment of castration-resistant prostate cancer include chemotherapy (docetaxel, cabazitaxel), androgen signaling inhibitors (abiraterone, enzalutamide) and systemic alpha-radiotherapy (radium-223 dichloride). Radium-223 is a radioactive calcium mimetic which selectively a...

Full description

Saved in:
Bibliographic Details
Main Authors: М. I. Volkova, A. S. Olshanskaya
Format: Artigo
Language:Russo
Published: ABV-press 2019-06-01
Series:Onkourologiâ
Subjects:
radium dichloride-223
alpha radiotherapy
castration-resistant prostate cancer
iii phase study alsympca
bone metastases
Online Access:https://oncourology.abvpress.ru/oncur/article/view/959
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items